169 related articles for article (PubMed ID: 27096721)
1. User-centered Design of the eyeGuide: A Tailored Glaucoma Behavior Change Program.
Killeen OJ; MacKenzie C; Heisler M; Resnicow K; Lee PP; Newman-Casey PA
J Glaucoma; 2016 Oct; 25(10):815-821. PubMed ID: 27096721
[TBL] [Abstract][Full Text] [Related]
2. Patient Experience during the Support, Educate, Empower Glaucoma Coaching Program to Improve Medication Adherence: A Pilot Study.
Hollenhorst CN; Elliott V; Heisler M; Schneider K; Resnicow K; Newman-Casey PA
Ophthalmol Glaucoma; 2020; 3(4):238-252. PubMed ID: 33008556
[TBL] [Abstract][Full Text] [Related]
3. The Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Pilot Study on Glaucoma Medication Adherence.
Newman-Casey PA; Niziol LM; Lee PP; Musch DC; Resnicow K; Heisler M
Ophthalmol Glaucoma; 2020; 3(4):228-237. PubMed ID: 33012330
[TBL] [Abstract][Full Text] [Related]
4. Feasibility, Patient Acceptability, and Preliminary Efficacy of a Culturally Informed, Health Promotion Program to Improve Glaucoma Medication Adherence Among African Americans: "Glaucoma Management Optimism for African Americans Living with Glaucoma" (GOAL).
Dreer LE; Owsley C; Campbell L; Gao L; Wood A; Girkin CA
Curr Eye Res; 2016; 41(1):50-8. PubMed ID: 25625187
[TBL] [Abstract][Full Text] [Related]
5. Communication Predicts Medication Self-Efficacy in Glaucoma Patients.
Carpenter DM; Blalock SJ; Sayner R; Muir KW; Robin AL; Hartnett ME; Giangiacomo AL; Tudor GE; Sleath BL
Optom Vis Sci; 2016 Jul; 93(7):731-7. PubMed ID: 27003815
[TBL] [Abstract][Full Text] [Related]
6. Factors Affecting Adherence to Topical Glaucoma Therapy: A Quantitative and Qualitative Pilot Study Analysis in Sydney, Australia.
Spencer SKR; Shulruf B; McPherson ZE; Zhang H; Lee MB; Francis IC; Bank A; Coroneo MT; Agar A
Ophthalmol Glaucoma; 2019; 2(2):86-93. PubMed ID: 32672609
[TBL] [Abstract][Full Text] [Related]
7. Improving adherence to glaucoma medication: a randomised controlled trial of a patient-centred intervention (The Norwich Adherence Glaucoma Study).
Cate H; Bhattacharya D; Clark A; Fordham R; Holland R; Broadway DC
BMC Ophthalmol; 2014 Mar; 14():32. PubMed ID: 24655814
[TBL] [Abstract][Full Text] [Related]
8. Glaucoma patient expression of medication problems and nonadherence.
Slota C; Sayner R; Vitko M; Carpenter DM; Blalock SJ; Robin AL; Muir KW; Hartnett ME; Sleath B
Optom Vis Sci; 2015 May; 92(5):537-43. PubMed ID: 25875690
[TBL] [Abstract][Full Text] [Related]
9. Glaucoma Patient Preferences for Video Education on Eye Drop Technique.
Davis SA; Carpenter DM; Blalock SJ; Budenz DL; Lee C; Muir KW; Robin AL; Sleath B
Optom Vis Sci; 2019 May; 96(5):325-330. PubMed ID: 31046014
[TBL] [Abstract][Full Text] [Related]
10. The relationship between quality of life and adherence to medication in glaucoma patients in Singapore.
Loon SC; Jin J; Jin Goh M
J Glaucoma; 2015; 24(5):e36-42. PubMed ID: 24248002
[TBL] [Abstract][Full Text] [Related]
11. Inpatient Adherence to Topical Glaucoma Medications before and after an Educational Intervention.
Mammo DA; Strampe M; Naravane A; Mallory PW; Boysen J; Wright MM
Ophthalmol Glaucoma; 2020; 3(5):339-342. PubMed ID: 32980036
[TBL] [Abstract][Full Text] [Related]
12. A Path Analysis of Effects of Patients' Underlying Conditions, Treatment Satisfaction, and Adherence on Quality of Life Among Korea Glaucoma Patients.
Kim CY; Park KH; Ahn J; Ahn MD; Cha SC; Kim HS; Kim JM; Kim MJ; Kim TW; Kim YY; Lee JW; Park SW; Sohn YH; Sung KR; Yoo C; Cha JH; Kim YJ; Lee J; Choi J
J Glaucoma; 2019 Sep; 28(9):785-789. PubMed ID: 31233453
[TBL] [Abstract][Full Text] [Related]
13. The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey.
Newman-Casey PA; Robin AL; Blachley T; Farris K; Heisler M; Resnicow K; Lee PP
Ophthalmology; 2015 Jul; 122(7):1308-16. PubMed ID: 25912144
[TBL] [Abstract][Full Text] [Related]
14. Text Parsing-Based Identification of Patients with Poor Glaucoma Medication Adherence in the Electronic Health Record.
Hamid MS; Valicevic A; Brenneman B; Niziol LM; Stein JD; Newman-Casey PA
Am J Ophthalmol; 2021 Feb; 222():54-59. PubMed ID: 32926847
[TBL] [Abstract][Full Text] [Related]
15. Readability of prescription labels and medication recall in a population of tertiary referral glaucoma patients.
O'Hare F; Jeganathan VS; Rokahr CG; Rogers SL; Crowston JG
Clin Exp Ophthalmol; 2009 Dec; 37(9):849-54. PubMed ID: 20092593
[TBL] [Abstract][Full Text] [Related]
16. Predicting Adherence With the Glaucoma Treatment Compliance Assessment Tool.
Sanchez FG; Mansberger SL; Newman-Casey PA
J Glaucoma; 2020 Nov; 29(11):1017-1024. PubMed ID: 32740508
[TBL] [Abstract][Full Text] [Related]
17. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.
Sleath B; Blalock S; Covert D; Stone JL; Skinner AC; Muir K; Robin AL
Ophthalmology; 2011 Dec; 118(12):2398-402. PubMed ID: 21856009
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Patient Education and Telemedicine Reminders on Adherence to Eye Drops for Glaucoma.
Lai Y; Wu Y; Chai C; Yen CC; Ho Y; Eng TC; Jain P; Koh V
Ophthalmol Glaucoma; 2020; 3(5):369-376. PubMed ID: 32980041
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy of the After-visit Summary in Medication Recall Among Glaucoma Patients.
Hirabayashi KJ; Pomerantz M; Radell JE; Chadha N; Thomas S; Serle JB
J Glaucoma; 2020 Jul; 29(7):529-535. PubMed ID: 32332333
[TBL] [Abstract][Full Text] [Related]
20. Facilitators and Barriers to Glaucoma Medication Adherence.
Gatwood J; Brooks C; Meacham R; Abou-Rahma J; Cernasev A; Brown E; Kuchtey RW
J Glaucoma; 2022 Jan; 31(1):31-36. PubMed ID: 34772874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
